Clinical Research Malaysia

CRM Trial Connect 2025 is ready to go! Mark your calendars on 8-9 May 2025, and join us for this one-stop clinical research event! Not to mention the Clinical Trials Day celebration and the Sponsored Research Awards ceremony, which will be in place in conjunction with this programme. Stay tuned for additional updates on the programme highlights, and reach out to event@clinicalresearch.my for more inquiry! #CRMTrialConnect2025 #ClinicalTrialsDay2025 #EarlyPhaseResearch #PatientEngagement

Congratulations to Dr Voon Pei Jye & study team of Sarawak General Hospital in enrolling their first patient in Malaysia for Non Small Cell Lung Cancer study. Kudos to our Study Coordinators, Lin Hui, Li Fang, Erfan & Haziqah for their contribution. Keep it up team! #clinicalresearchmy #advancingclinicalresearch⁠ #askusaboutclinicalresearch⁠ #recruitmentachievement

We are looking for patients with Hypertension condition. Visit the link below if you are interested to partake in our clinical trial! https://lnkd.in/gN47ZpEt #findaclinicaltrial #clinicalresearchmy #hypertension

We are looking for patients with HIV-1 infection condition. Visit the link below if you are interested to partake in our clinical trial! https://lnkd.in/dX3U9USM #findaclinicaltrial #clinicalresearchmy #HIVinfection

CRM had the opportunity to meet with Novugen representatives, Mr. Saif-ur-Rehman, Vice President of Commercial, Mr. Jacob Gwee, Head of Key Account Management and Dr. Azeem Rauf, Medical Affairs Manager. Our discussion centered on CRM’s role as a site management organization for clinical trials in Malaysia as well as the Novugen’s accomplishments. With Novugen’s status as the sole USFDA approved oncology manufacturing plant in Southeast Asia, there is much to explore in terms of clinical research collaboration, especially in real-world studies.

Meet-up with Mr Mohan Manthiry, Founder & CEO of InfoMed. Discussion revolve around precision health, generative AI and collaboration with international organisations in this space to improve screening and early detection of diseases.

CRM recently hosted delegates from several biopharmaceutical organisations from China. The business meeting held at CRM HQ prepared a platform for the delegates to directly engage with key stakeholders in Malaysia (including CRM, NPRA and MIDA) to understand the landscape of clinical trial, regulatory requirements and investment incentives in Malaysia. The delegates then proceeded for a site visit at Kuala Lumpur Hospital. The growth of CGTP trials from China represent an opportunity for innovative therapies particularly in addressing the unmet medical needs of disease condition in the country.

At the Malaysia Thoracic Society Annual Congress 2024 held over the weekend, CRM's Chief Executive Officer, Dr Akhmal Yusof, highlighted the vital role of Pulmonologists and Chest Physicians as investigators in respiratory and lung cancer clinical trials. With 14 respiratory studies and 17 lung cancer studies conducted in 2023 alone, the congress was an invaluable platform for networking and collaboration opportunities with experts and researchers in the field.

CRM mengucapkan Selamat Hari Merdeka yang ke 67 buat seluruh rakyat Malaysia! Meraikan Malaysia Madani: Jiwa Merdeka, mari kita teruskan semangat perpaduan dan kesatuan untuk membina masa depan yang lebih gemilang. Bersama, kita raikan kemerdekaan dengan penuh rasa bangga dan cinta kepada tanah air tercinta. #MalaysiaMADANI #JiwaMerdeka #clinicalresearchmy #advancingclinicalresearch #askusaboutclinicalresearch

CRM is now on TikTok! Visit the link below to view our first video! https://lnkd.in/gRrGKxb5 #clinicalresearchmy #advancingclinicalresearch⁠ #askusaboutclinicalresearch⁠